CANFOR PULP PRODUCTS INC (CFX.CA) Stock Fundamental Analysis
TSX:CFX - Toronto Stock Exchange - CA1375842079 - Common Stock - Currency: CAD
We assign a fundamental rating of 2 out of 10 to CFX. CFX was compared to 12 industry peers in the Paper & Forest Products industry. CFX has a bad profitability rating. Also its financial health evaluation is rather negative. CFX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CFX has reported negative net income.
CFX had a positive operating cash flow in the past year.
CFX had negative earnings in each of the past 5 years.
CFX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -37.82%, CFX is doing worse than 91.67% of the companies in the same industry.
With a Return On Equity value of -102.65%, CFX is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -37.82% | ||
| ROE | -102.65% | ||
| ROIC | N/A |
ROA(3y)-9.99%
ROA(5y)-7.14%
ROE(3y)-18.66%
ROE(5y)-13.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CFX has a Gross Margin (20.04%) which is in line with its industry peers.
CFX's Gross Margin has declined in the last couple of years.
CFX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.99%
GM growth 5Y-20.63%
2. Health
2.1 Basic Checks
CFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFX remains at a similar level compared to 1 year ago.
The number of shares outstanding for CFX remains at a similar level compared to 5 years ago.
CFX has a worse debt/assets ratio than last year.
2.2 Solvency
CFX has an Altman-Z score of 0.70. This is a bad value and indicates that CFX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.70, CFX is doing worse than 83.33% of the companies in the same industry.
CFX has a debt to FCF ratio of 5.55. This is a neutral value as CFX would need 5.55 years to pay back of all of its debts.
The Debt to FCF ratio of CFX (5.55) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that CFX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, CFX is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.55 | ||
| Altman-Z | 0.7 |
ROIC/WACCN/A
WACC9.68%
2.3 Liquidity
A Current Ratio of 0.91 indicates that CFX may have some problems paying its short term obligations.
CFX's Current ratio of 0.91 is on the low side compared to the rest of the industry. CFX is outperformed by 83.33% of its industry peers.
A Quick Ratio of 0.35 indicates that CFX may have some problems paying its short term obligations.
The Quick ratio of CFX (0.35) is worse than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.35 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 84.26% over the past year.
Looking at the last year, CFX shows a very negative growth in Revenue. The Revenue has decreased by -12.67% in the last year.
Measured over the past years, CFX shows a decrease in Revenue. The Revenue has been decreasing by -8.62% on average per year.
EPS 1Y (TTM)84.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
Revenue 1Y (TTM)-12.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-8.62%
Sales Q2Q%2.33%
3.2 Future
CFX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.45% yearly.
The Revenue is expected to decrease by -3.96% on average over the next years.
EPS Next Y81.57%
EPS Next 2Y37.92%
EPS Next 3Y24.73%
EPS Next 5Y7.45%
Revenue Next Year-6.11%
Revenue Next 2Y-6.54%
Revenue Next 3Y-3.96%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CFX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CFX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than CFX, based on the Enterprise Value to EBITDA ratio.
CFX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CFX is cheaper than 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.85 | ||
| EV/EBITDA | 0.64 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CFX's earnings are expected to grow with 24.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.92%
EPS Next 3Y24.73%
5. Dividend
5.1 Amount
CFX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CFX (2/21/2025, 7:00:00 PM)
0.79
-0.03 (-3.66%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners20.01%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap51.53M
Analysts71.11
Price Target1.43 (81.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.24%
Min EPS beat(2)17.49%
Max EPS beat(2)67%
EPS beat(4)4
Avg EPS beat(4)52.04%
Min EPS beat(4)17.49%
Max EPS beat(4)72.69%
EPS beat(8)4
Avg EPS beat(8)-116.71%
EPS beat(12)6
Avg EPS beat(12)-112.77%
EPS beat(16)9
Avg EPS beat(16)-77.04%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.82%
Revenue beat(4)3
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-4.37%
Max Revenue beat(4)1.82%
Revenue beat(8)4
Avg Revenue beat(8)-0.18%
Revenue beat(12)8
Avg Revenue beat(12)1.29%
Revenue beat(16)9
Avg Revenue beat(16)0.62%
PT rev (1m)-6.67%
PT rev (3m)-6.67%
EPS NQ rev (1m)8.82%
EPS NQ rev (3m)27.91%
EPS NY rev (1m)7.69%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)3.67%
Revenue NQ rev (3m)-14.78%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | 2.85 | ||
| P/OCF | 0.61 | ||
| P/B | 0.3 | ||
| P/tB | 0.3 | ||
| EV/EBITDA | 0.64 |
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.28
FCFY35.12%
OCF(TTM)1.3
OCFY164.36%
SpS12.72
BVpS2.66
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -37.82% | ||
| ROE | -102.65% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.04% | ||
| FCFM | 2.18% |
ROA(3y)-9.99%
ROA(5y)-7.14%
ROE(3y)-18.66%
ROE(5y)-13.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.99%
GM growth 5Y-20.63%
F-Score5
Asset Turnover1.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.55 | ||
| Debt/EBITDA | 2.62 | ||
| Cap/Depr | 99.7% | ||
| Cap/Sales | 8.03% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 222.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.35 | ||
| Altman-Z | 0.7 |
F-Score5
WACC9.68%
ROIC/WACCN/A
Cap/Depr(3y)92.15%
Cap/Depr(5y)95.3%
Cap/Sales(3y)8.05%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
EPS Next Y81.57%
EPS Next 2Y37.92%
EPS Next 3Y24.73%
EPS Next 5Y7.45%
Revenue 1Y (TTM)-12.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-8.62%
Sales Q2Q%2.33%
Revenue Next Year-6.11%
Revenue Next 2Y-6.54%
Revenue Next 3Y-3.96%
Revenue Next 5YN/A
EBIT growth 1Y79.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.54%
EBIT Next 3Y33.6%
EBIT Next 5Y20.88%
FCF growth 1Y130.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.1%
OCF growth 3Y-27.69%
OCF growth 5Y-29.95%